Previous close | 358.71 |
Open | 359.20 |
Bid | 358.01 x 900 |
Ask | 358.25 x 800 |
Day's range | 355.68 - 359.50 |
52-week range | 249.98 - 361.41 |
Volume | |
Avg. volume | 1,325,598 |
Market cap | 136.405B |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | 43.48 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.20 (0.89%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 9, 2024 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. To listen to the meeting as a guest dial (877) 3
AMSTERDAM, March 26, 2024--Stryker's Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France-based joint replacement company, from Menix.